MedPath

The effect of Withania somnifera on anxiety symptoms in children with ADHD

Phase 3
Conditions
Attention- Deficit Hyperactivity Disorders.
Attention-deficit hyperactivity disorders
Registration Number
IRCT20180723040567N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
28
Inclusion Criteria

Diagnosis of ADHD based on DSM-5 criteria
aged 7-12 years
Complete consent form by parent or guardian
Normal IQ
Symptoms of simultaneous anxiety

Exclusion Criteria

The patient's unwillingness to participating in the research project
Systemic disease
Interventional psychiatric illness
intellectual disability

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety symptoms in children with ADHD. Timepoint: At the beginning of STUDY and the week 3 and 6. Method of measurement: Child Anxiety Test based on the revised child anxiety scale(RCMA).;Symptoms of ADHD. Timepoint: Weeks 3 and 6. Method of measurement: ADHD rating scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath